NCT03740165 2025-10-22KEYLYNK-001Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,367 enrolled 29 charts
NCT01015118 2017-12-07LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian CancerBoehringer IngelheimPhase 3 Completed1,366 enrolled 17 charts
NCT00191646 2011-03-04An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyEli Lilly and CompanyPhase 3 Completed919 enrolled 18 charts